March 19, 1991: Genetic-Modified Bacteria E. Coli Granted by USPTO

2018-03-19|

March 19, 1991: Genetic-Modified Bacteria E. Coli Granted by USPTO

by GeneOnline

Share To

On March 19, 1991, the United States Patent and Trademark Office (USPTO) issued a patent US5000000A to scientists at the University of Florida for their invention of genetic-modified Escherichia coli strains with ability to produce ethanol as a fermentation product. The genetically modified bacterial strains can convert wood, whey, waste paper, or garden waste into ethanol as fuel.

Reference
http://www.google.com/patents/US5000000

Author

GeneOnline

Licensing

US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid

2022-06-22

Special

Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court

2022-06-17

Regulatory

Illumina to Pay BGI $333M Following Infringement Case

2022-05-09

LATEST

Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm

2024-10-04

TCELS’s Path to a Self-Sufficient Biotech Thailand: Entrepreneurs in Global Competitiveness, Raw Material Exports, and Cosmetic Innovations

2024-10-04

Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing

2024-10-03

Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?

2024-10-03

2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments

2024-09-30

Eyes on Nvidia: A Strong Investment Prospect, Driving Billions in AI Development and Advanced Infrastructure

2024-09-30

Immunai and AstraZeneca’s $18 Million AI Collaboration to Transform Cancer Drug Development

2024-09-26

EVENT

2024-10-09

Medical Japan 2024 Tokyo

Tokyo, Japan

2024-10-10

BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024

Tokyo, Japan

2024-10-15

BIO Investor Forum 2024

San Francisco, U.S.A.

2024-10-28

BioFuture 2024

New York, U.S.A.

2024-10-30

AusBiotech 2024

Melbourne, Australia

2024-11-04

BIO-Europe 2024

Stockholm, Sweden

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog